Table 2.

Clinical demographics of patient groups from three NSCLC patient cohorts

Brigham & Women's Hospital*U.S. BiomaxM.D. Anderson Cancer Center
No. of patients86155225
AgeMedian (range)68(34-84)56(30-78)67(33-90)
DiagnosisAdenocarcinoma86100%10970%13861%
SqCC00%4630%8739%
GenderFemale5665%5133%11551%
Male3035%10467%11049%
DifferentiationWell (1)1011%2315%4922%
Moderate (2)4148%6240%11250%
Poor (3)3541%6643%6428%
Tumor status (T)T13237%§§8437%
T24047%§§11852%
T333%§§104%
T41113%§§136%
Nodal status (N)N05564%§§15569%
N11315%§§4520%
N2910%§§2511%
Distant metastasisAbsent/undetected7790%§§21796%
Present910%§§84%
Smoking statusCurrent4249%§§7835%
Former2327%§§11350%
Never1012%§§3415%
Pathologic stageIA & IB§§§§13962%
IIA & IIB§§§§4620%
IIIA & IIIB§§§§3114%
IV§§§§84%
  • *IHC was done using the 6.1B antibody.

  • IHC was done using the 468642 antibody.

  • Missing individual patient information for U.S. Biomax TMAs.

  • §Data not available for any patients.

  • Missing individual patient information for Brigham and Women's Hospital TMA.

  • Missing individual patient information for M.D. Anderson Cancer Center TMA.